Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 2029-2034

  Machens, Andreas ^a   Schneyer, Ulrich ^a   Holzhausen, Hans Jürgen ^a   Dralle, Henning ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN;

ADULT; ARTICLE; CALCITONIN BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; THYROID MEDULLARY CARCINOMA; VENOUS BLOOD;

ADOLESCENT; ADULT; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; FEMALE; HUMANS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; THYROID NEOPLASMS;

EID: 17844400055     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1836     Document Type: Article

References (27)

1. Moley JF, DeBenedetti MK, Dilley WG, Tisell LE, Wells SA 1998 Surgical management of patients with persistent or recurrent medullary thyroid cancer. J Intern Med 243:521-526
2. Modigliani E, Cohen R, Campos JM, Conte-Devolx B, Maes B, Boneu A, Schlumberger M, Bigorgne JC, Dumontier P, Ledere L, Corcuff B, Guilhem I, and the GETC Study Group 1998 Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. Clin Endocrinol (Oxf) 48:265-273
3. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E 1992 Frequency and significance of cervicomediastinal lymph node metastases in medullary thyroid carcinoma: results of a compartment-oriented microdissection method. Henry Ford Hosp Med J 40:264-267
4. Weber T, Schilling T, Frank-Kaue K, Colombo-Benkmann M, Hinz U, Ziegler R, Klar H 2001 Impact of modified radical neck dissection on biochemical cure in medullary thyroid carcinomas. Surgery 130:1044-1049
5. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075
6. Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H 2000 Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer 88:1909-1915
7. Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B 1999 Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089-1096
8. Cohen R, Campos JM, Salaun C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E 2000 Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs à Calcitonine (GETC). J Clin Endocrinol Metab 85:919-922
9. Röher HD, Simon D, Goretzki PE 1997 Guidelines in oncologic surgery: malignant thyroid tumors. Langenbecks Arch Surg 114(Suppl 2):142
10. Guilloteau D, Perdrisot R, Calmettes C, Baulieu JL, Lecomte P, Kaphan G, Milhaud G, Besnard JC, Jallet P, Bigorgne JC 1990 Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulated test in hereditary MCT. J Clin Endocrinol Metab 71:1064-1067
11. Perdisot R, Bigorgne JC, Guilloteau D, Jallet P 1990 Monoclonal immunoradiometric assay of calcitonin improves investigation of familial medullary thyroid carcinoma. Clin Chem 36:381-383
12. Machens A, Hinze R, Thomusch O, Dralle H 2002 Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26:22-28
13. Hinze R, Holzhausen HJ, Gimm O, Dralle H, Rath FW 1998 Primary hereditary medullary thyroid carcinoma: C-cell morphology and correlation with preoperative calcitonin levels. Virchows Arch 433:203-208
14. Kaplan EL, Meier P 1958 Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
15. Cox DR 1972 Regression models and life tables. J R Stat Soc 34:187-220
16. Hennekens CH, Buring JE, Mayrent SL, eds 1987 Epidemiology in medicine. Boston/Toronto: Little, Brown; 222
17. Franc S, Niccoli-Sire P, Cohen R, Bardet S, Maes B, Murat A, Krivitzky A, Modigliani E, French Medullary Study Group (GETC) 2001 Complete surgical lymph node resection does not prevent authentic recurrences of medullary thyroid carcinoma. Clin Endocrinol (Oxf) 55:403-409
18. Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F 2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163-168
19. Dottorini ME, Assi A, Sironi M, Sangalli G, Spreafico G, Colombo L 1996 Multivariate analysis of patients with medullary thyroid carcinoma: prognostic significance and impact on treatment of clinical and prognostic variables. Cancer 77:1556-1565
20. Bieglmayer C, Scheuba C, Niederle B, Flores J, Vierhapper H 2002 Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr 114:267-273
21. Hodak SP, Burman KD 2004 Editorial: the calcitonin conundrum: is it time for routine measurement of serum calcitonin in patients with thyroid nodules? J Clin Endocrinol Metab 89:511-514
22. Machens A, Holzhausen HJ, Lautenschläger C, Thanh PN, Dralle H 2003 Enhancement of lymph node metastasis and distant metastasis of thyroid carcinoma. A multivariate analysis of clinical risk factors. Cancer 98:712-719
23. Esik O, Szavcsur P, Szakáll Jr S, Bajzik G, Repa I, Dabasi G, Füzy M, Szentirmay Z, Perner F, Kásler M, Lengyel Z, Trón L 2001 Angiography effectively supports the diagnosis of hepatic metastases in medullary thyroid carcinoma. Cancer 91:2084-2095
24. Tung WS, Vesely TM, Moley JF 1995 Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer. Surgery 118:1024-1030
25. Mirallie E, Vuillez JP, Bardet S, Frampas E, Dupas B, Ferrer L, Faivre-Chauvel A, Murat A, Charbonnel B, Barbet J, Goldenberg DM, Chatal JF, Kraeber-Bodere F 2005 High frequency of bone/bone marrow involvement in advanced medullary thyroid cancer. J Clin Endocrinol Metab 90:779-788
26. Leboulleux S, Baudin E, Travagli JP, Schlumberger M 2004 Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61:299-310
27. Yen TWF, Shapiro SB, Gagel RF, Sherman SI, Lee JE, Evans DB 2003 Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Surgery 134:890-901